M.V.I.-12 ADULT
LOE Approachingascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin; thiamine hydrochloride; vitamin a; vitamin e
NDAINJECTIONINJECTABLE
Approved
Feb 1953
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 12h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
M.V.I.-12 ADULT is a parenteral multivitamin formulation containing 12 essential vitamins (A, B-complex, C, D, E) administered by injection for nutritional support in patients unable to meet vitamin requirements orally. It provides comprehensive micronutrient repletion in hospitalized, critically ill, or post-operative patients. The product works through direct supplementation of water-soluble and fat-soluble vitamins essential for metabolic, immune, and neurological function.
LOE Approaching
Long-established injectable vitamin product nearing loss of exclusivity with moderate competitive pressure (30/100), likely requiring smaller, maintenance-focused commercial team focused on hospital formulary and IDN relationships.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on M.V.I.-12 ADULT offers career experience in mature product management, hospital relationship building, and cost-based competitive strategy within a stable but low-growth category. This role is ideal for professionals seeking to develop formulary expertise and healthcare system navigation skills rather than high-growth commercial opportunity.
Account ManagerHospital Sales Representative
Worked on M.V.I.-12 ADULT at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.